Literature DB >> 10146247

Glucose-sensitive polymeric matrices for controlled drug delivery.

M Goldraich1, J Kost.   

Abstract

Hydrogel matrices were prepared by chemical polymerization of solutions containing 2-hydroxyethyl methacrylate, N,N-dimethyl-aminoethyl methacrylate, tetraethylene glycol dimethacrylate, ethylene glycol and water solutions containing glucose oxidase, bacitracin or insulin. The hydrogels displayed faster and higher swelling and release rates at lower pH or at higher glucose concentrations. Swelling and release kinetics were also responsive to step changes in glucose concentration in the physiological range. The kinetics of the soluble and immobilized enzyme followed Michaelis Menten's kinetics. In the soluble state the enzyme was more active than the immobilized one due to mass transfer limitations, which may be overcome by preparation of microbead configuration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 10146247     DOI: 10.1016/0267-6605(93)90100-l

Source DB:  PubMed          Journal:  Clin Mater        ISSN: 0267-6605


  4 in total

1.  Separation of the effects of pH and polymer concentration on the swelling pressure and elastic modulus of a pH-responsive hydrogel.

Authors:  Ferenc Horkay; Man-Hee Han; In Suk Han; In-Seok Bang; Jules J Magda
Journal:  Polymer (Guildf)       Date:  2006-10-04       Impact factor: 4.430

Review 2.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

3.  Glucose-responsive insulin by molecular and physical design.

Authors:  Naveed A Bakh; Abel B Cortinas; Michael A Weiss; Robert S Langer; Daniel G Anderson; Zhen Gu; Sanjoy Dutta; Michael S Strano
Journal:  Nat Chem       Date:  2017-09-22       Impact factor: 24.427

4.  Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats.

Authors:  Efstathios Karathanasis; Rohan Bhavane; Ananth V Annapragada
Journal:  Int J Nanomedicine       Date:  2007
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.